X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aβ1-42 (85) 85
alzheimer's disease (67) 67
index medicus (55) 55
humans (33) 33
alzheimers-disease (27) 27
alzheimer’s disease (27) 27
neurosciences (26) 26
a beta 1-42 (25) 25
animals (24) 24
male (22) 22
neurology (18) 18
aβ1–42 (15) 15
amyloid beta-peptides - metabolism (14) 14
mice (13) 13
alzheimer disease - metabolism (12) 12
biochemistry & molecular biology (12) 12
mild cognitive impairment (12) 12
tau (12) 12
biomarkers (11) 11
brain (11) 11
female (11) 11
aged (10) 10
alzheimer disease - pathology (10) 10
dementia (10) 10
rats (10) 10
a-beta (9) 9
amyloid beta-peptides - toxicity (9) 9
cerebrospinal fluid (9) 9
clinical neurology (9) 9
middle aged (9) 9
peptide fragments - metabolism (9) 9
a beta (8) 8
amyloid beta-peptides - cerebrospinal fluid (8) 8
article (8) 8
aβ1-40 (8) 8
biomarkers - cerebrospinal fluid (8) 8
diagnosis (8) 8
hippocampus (8) 8
neurodegeneration (8) 8
oxidative stress (8) 8
alzheimer disease - genetics (7) 7
aβ1-42 peptide (7) 7
cerebrospinal-fluid (7) 7
chemistry, medicinal (7) 7
cognitive ability (7) 7
memory (7) 7
peptide fragments - toxicity (7) 7
pharmacology & pharmacy (7) 7
protein (7) 7
rats, sprague-dawley (7) 7
aged, 80 and over (6) 6
alzheimers disease (6) 6
amyloid (6) 6
amyloid-beta (6) 6
biophysics (6) 6
csf (6) 6
enzyme-linked immunosorbent assay (6) 6
geriatrics & gerontology (6) 6
hippocampus - drug effects (6) 6
inflammation (6) 6
internal medicine (6) 6
mouse model (6) 6
neurology. diseases of the nervous system (6) 6
peptide fragments - cerebrospinal fluid (6) 6
peptide fragments - pharmacology (6) 6
phosphorylation (6) 6
research (6) 6
time factors (6) 6
aggregation (5) 5
alzheimer disease - cerebrospinal fluid (5) 5
alzheimer disease - diagnosis (5) 5
alzheimer disease - drug therapy (5) 5
amyloid beta-peptides - blood (5) 5
amyloid beta-peptides - chemistry (5) 5
amyloid beta-peptides - pharmacology (5) 5
association (5) 5
cells, cultured (5) 5
csf biomarkers (5) 5
cytotoxicity (5) 5
disease models, animal (5) 5
maze learning - drug effects (5) 5
neurodegenerative diseases (5) 5
neuroprotective agents - pharmacology (5) 5
oligomers (5) 5
p-tau (5) 5
peptide (5) 5
peptide fragments - chemistry (5) 5
psychiatry (5) 5
tau protein (5) 5
tau proteins - cerebrospinal fluid (5) 5
water-soluble prodrugs (5) 5
a beta 1-40 (4) 4
activation (4) 4
alzheimer disease - psychology (4) 4
amino acid sequence (4) 4
amyloid beta-peptides - antagonists & inhibitors (4) 4
amyloid beta-peptides - genetics (4) 4
amyloid beta-protein (4) 4
amyloid precursor protein (4) 4
apoe (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurobiology of Disease, ISSN 0969-9961, 2005, Volume 18, Issue 3, pp. 459 - 465
Activated glia, as a result of chronic inflammation, are associated with amyloid-β peptide (Aβ) deposits in the brain of Alzheimer's disease (AD) patients. In... 
Inducible nitric oxide synthase (iNOS) | Amyloid-β (Aβ) | Tumor necrosis factor-α (TNF-α) | Fibrillar Aβ1–42 | Interleukin-1β (IL-1β) | Inflammation | Oligomeric Aβ1–42 | Astrocyte | Alzheimer's disease | Nitric oxide (NO) | Fibrillar Aβ1-42 | Oligomeric Aβ1-42
Journal Article
Tetrahedron Letters, ISSN 0040-4039, 2004, Volume 45, Issue 31, pp. 5965 - 5968
Aβ1-42 was prepared via the synthesis of its water-soluble -acyl isopeptide, `26- -acyl isoAβ1-42'. A novel water-soluble isopeptide of Alzheimer's... 
Difficult sequence | 26- O-acyl isoAβ1-42 | Water-soluble Aβ1-42 isopeptide | O– N intramolecular acyl migration reaction | Alzheimer's disease | Aβ1-42 | 26-O-acyl isoAβ1-42 | O-N intramolecular acyl migration reaction
Journal Article
Neurología, ISSN 0213-4853, 2010, Volume 27, Issue 1, pp. 28 - 33
Resumen Introducción En muchos artículos recientes, el análisis de las proteínas Aβ1-42 , tau total (T-tau) y tau fostorilada (P-tau) en LCR puede discriminar... 
Neurology | Deterioro cognitivo leve | Proteína T-tau | Proteína P-tau181p | Mild cognitive impairment | P-tau181p protein | Proteína Aβ1-42 | Enfermedad de Alzheimer | Aβ1-42 protein | CSF biomarkers | T-tau protein | Alzheimer's disease | Biomarcadores en LCR
Journal Article
Neurología (English Edition), ISSN 2173-5808, 01/2012, Volume 27, Issue 1, pp. 28 - 33
Some studies have shown that CSF amyloid-beta 1-42 (Aβ ), total tau (T-tau) and tau phosphorylated at threonine 181 (P-tau ) proteins are useful diagnostic... 
Deterioro cognitivo leve | Proteína T-tau | Proteína P-tau181p | Mild cognitive impairment | P-tau181p protein | Proteína Aβ1-42 | Enfermedad de Alzheimer | Aβ1-42 protein | CSF biomarkers | T-tau protein | Alzheimer's disease | Biomarcadores en LCR
Journal Article
Toxicology Letters, ISSN 0378-4274, 01/2018, Volume 282, pp. 100 - 108
Alzheimer’s disease (AD) is a chronic neurodegenerative disease, which is characterized by the extracellular deposition of β-amyloid (Aβ). Previous studies... 
Oxidative stress | 3-MA | Autophagy | Apoptosis | Aβ1-42
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 07/2019, Volume 129, pp. 1 - 12
Oleuropein aglycone (OleA), the most abundant polyphenol in extra virgin olive oil (EVOO), and Hydroxythyrosol (HT), the OleA main metabolite, have attracted... 
Hydroxytyrosol | Aβ1-42 peptide | Oleuropein aglycone | Amyloid | Alzheimer's disease
Journal Article
Protein Expression and Purification, ISSN 1046-5928, 12/2019, Volume 164, p. 105480
Alzheimer's disease (AD) is a progressive neurological disease marked by the accumulation and deposition of misfolded amyloid beta or Abeta (Aβ) peptide. Two... 
NMR | Expression | Alzheimer's disease | Aβ1-42 | Solubility tag
Journal Article
European Review for Medical and Pharmacological Sciences, ISSN 1128-3602, 2018, Volume 22, Issue 7, pp. 2015 - 2021
In Alzheimer's disease (AD), astrocytes are generally found in the surrounding of senile plaques participating in the production of phagocytosis and the... 
Astrocytes | JNK/AP-1 pathway | Apoptosis | Aβ1-42
Journal Article
Journal of Molecular Biology, ISSN 0022-2836, 02/2010, Volume 396, Issue 1, pp. 9 - 18
Aggregation of the amyloid-β (Aβ) peptide is considered a central event in the pathogenesis of Alzheimer's disease (AD). In order to bypass methodological bias... 
amyloid | neurotoxicity | Aβ1–42 | Alzheimer's disease | protein misfolding | Aβ1-42
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 11/2019, Volume 182, p. 111613
Alzheimer's disease (AD) is associated with multifactorial neuropathological conditions, which include cholinergic deficit, amyloid-beta plaques formation,... 
Amyloid-beta (Aβ1-42) | Alzheimer's disease | Cholinesterases and multi-target directed ligands | Benzoxazole
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 05/2019, Volume 364, pp. 62 - 74
Neuronostatin (NST) is composed of a 13-amino acid and amidated peptide hormone encoded in the somatostatin (SST) gene, and plays an important physiological... 
Inflammation | Glucose | G-protein-coupled receptor 107 | Memory | Neuronostatin | Aβ1-42
Journal Article
Pathology - Research and Practice, ISSN 0344-0338, 10/2018, Volume 214, Issue 10, pp. 1583 - 1595
Numerous experimental studies and clinical observations suggest that cerebral ischemia may contribute to the pathogenesis of Alzheimer’s disease (AD).... 
Cerebral ischemia | Alzheimer’s disease | Two-vessel occlusion | Aβ1-42
Journal Article
Pathology Research and Practice, ISSN 0344-0338, 10/2018, Volume 214, Issue 10, pp. 1583 - 1595
Numerous experimental studies and clinical observations suggest that cerebral ischemia may contribute to the pathogenesis of Alzheimer's disease (AD).... 
Cerebral ischemia | Two-vessel occlusion | Alzheimer's disease | Aβ1-42
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 03/2017, Volume 322, pp. 145 - 156
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with cognitive impairment and major neuropathologic hallmark of amyloid-beta (Aβ) peptides.... 
Alzheimer’s disease | Risperidone | Cognitive impairment | Aβ1-42 | Alzheimer's disease
Journal Article
Neurochemistry International, ISSN 0197-0186, 09/2017, Volume 108, pp. 157 - 168
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease and a growing health problem worldwide. Because the drugs currently used to treat AD... 
Caenorhabditis elegans | Alzheimer's disease | Oxoisoaporphine alkaloid derivative | SH-SY5Y cell | Aβ1-42 | | Index Medicus
Journal Article